Acadian Asset Management’s Boundless Bio BOLD Stock Holding History

Acadian Asset Management’s Portfolio BOLD Stock Details BOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$365K	Buy	146,757 +134,147	+1,064%	+$207K	﹤0.01%	1520
2026 Q1	$12K	Hold	12,610	–	–	﹤0.01%	1973
2025 Q4	$14K	Sell	12,610 -1,143	-8%	-$1.42K	﹤0.01%	1920
2025 Q3	$16K	Hold	13,753	–	–	﹤0.01%	1784
2025 Q2	$13K	Sell	13,753 -8,334	-38%	-$11.1K	﹤0.01%	1603
2025 Q1	$31K	Hold	22,087	–	–	﹤0.01%	1493
2024 Q4	$63K	Buy	+22,087	New	+$64.4K	﹤0.01%	1429

Other funds holding BOLD

AVM

Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Acadian Asset Management's BOLD Position: Q2 2026 in Review

Acadian Asset Management increased its Boundless Bio (BOLD) stake by 1,064% in Q2 2026, buying an estimated $207K and bringing the position to 146,757 shares worth $365K. The position accounts for ﹤0.01% of the portfolio, ranked #1520.

Acadian Asset Management first reported a position in BOLD in Q4 2024 and has held it in 7 quarters since. 40 funds tracked by Wall St. Rank hold BOLD as of Q2 2026.

Acadian Asset Management held 146,757 shares of Boundless Bio worth $365K as of Q2 2026.
Acadian Asset Management bought 134,147 Boundless Bio shares in Q2 2026, an estimated $207K.
Boundless Bio made up ﹤0.01% of Acadian Asset Management's portfolio in Q2 2026, its #1520 holding.
Acadian Asset Management first reported a position in Boundless Bio in Q4 2024 and has held it in 7 quarters since.
40 funds tracked by Wall St. Rank held Boundless Bio as of Q2 2026.

Based on Acadian Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.